Size: px
Start display at page:

Download ""

Transcription

1

2

3

4 Financial 13% Strategic 87% Amount Date Target Buyer(s) Segment Rev EBITDA 6/28/2018 Keryx Biopharmaceuticals, Inc. Akebia Therapeutics, Inc. Medical Product Distribution x - 6/19/2018 Foundation Medicine, Inc. Roche Holding AG Provider Services 5, x - 6/11/2018 Envision Healthcare Corp. KKR & Co. LP Provider Services 9, x 8.88x 6/4/2018 Elliquence LLC Shanghai Xianfeng Investment Medical Devices & Products x - Management Co. Ltd. 5/16/2018 ABAXIS, Inc. Zoetis, Inc. Medical Devices & Products 1, x 37.11x 4/25/2018 HCR ManorCare, Inc. ProMedica Health Systems, Inc. Long Term & Behavioral 1, x - Care 4/10/2018 Analogic Corp. Altaris Capital Partners LLC Medical Devices & Products x 18.83x 4/3/2018 LifeGlobal Group LLC CooperSurgical, Inc. Medical Devices & Products x - 4/3/2018 Humco Holding Group, Inc. Fagron NV Pharma Services x - 3/16/2018 LifeScan, Inc. Platinum Equity LLC Medical Devices & Products 2, x - 3/12/2018 Cogentix Medical, Inc. LABORIE Medical Technologies, Inc.; Medical Devices & Products x - Patricia Industries AB 3/8/2018 Express Scripts Holding Co. Cigna Corp. Pharma Services 67, x 9.27x 1/21/2018 Bioverativ, Inc. Sanofi Medical Devices & Products 10, x 23.13x

5 Strategic Buyer 3/14/2017 Inv. Date Select Corporate Acquisitions Agemark Senior Living 4/30/2018 Social Circle LLC 4/30/2018 Gainesville ALF LLC 4/30/2018 Rome ALF LLC 4/6/2018 Healthcare Management Partners LLC/ 8 Sub/ MEDNAX 4/24/2018 Women's Radiology Associates LLP 4/2/2018 Children's Urology Associates PA 3/27/2018 Cool Springs Interventional PLLC 3/21/2018 Children's Eye Care LLC 1/10/2018 Tri-Valley Neonatal Medical Group, Inc. 10/18/2017 Synergy Radiology Associates, PA 10/2/2017 Palm Beach Pediatric Urology P.A 9/28/2017 Jefferson Radiology PC / Jefferson Imaging Associates LLC Boston Scientific Corp. 4/16/2018 nvision Medical Corp. 4/3/2018 Securus Medical Group, Inc. 3/21/2018 NxThera, Inc. 1/24/2018 Millipede, Inc. 10/2/2017 Apama Medical, Inc. 9/27/2016 EndoChoice Holdings, Inc. Envision Healthcare Corp. 4/10/2018 Dallas Lighthouse For The Blind, Inc. 3/1/2018 Chandler Radiology Associates LLP 7/5/2017 Infinity Healthcare, Inc. 6/29/2017 Anesthesia Associates of New London PC 3/7/2017 Imaging Advantage LLC 1/6/2017 Emergency Professional Services PC Financial Buyer Inv. Date Select Corporate Investments New MainStream Capital 6/1/2018 Drs. Melman, Ravett & Associates PC 4/30/2018 Tideway Dermatology PA 4/5/2018 Kremer Eye Center 2/5/2018 East Tennessee Dermatology Group PC 1/15/2018 Chattanooga Dental Care Spindletop Capital Management LLC 5/15/2018 Sanova Dermatology Management, Inc. 5/15/2018 Steiner Ranch Dermatology & Cosmetic Surgery PLLC 5/15/2018 Pflugerville Dermatology Clinical Research Center 5/15/2018 The Austin Institute For Clinical Research 5/15/2018 Furner Bonnie MD Pllc 5/15/2018 The DermaSurgery Center LLC Gryphon Investors 3/9/2018 Newbury Park Dental Studio 3/7/2018 Accent Physical Therapy LLC 3/7/2018 Champion Physical Therapy LLC 3/7/2018 Professional Therapies of Roanoke, Inc. 3/7/2018 West Rehab & Sports Mediicine, Inc. 11/1/2017 Emergency Response & Training Solutions, Inc. 7/6/2017 OB Hospitalist Group, Inc. 6/26/2017 Spine & Sport Foundation, Inc. SV Health Investors 3/6/2018 Dermone LLC (Clinics 9) (Clear Clinic & Schweiger Dermatology Management Co.) 9/12/2017 Island Dermatology PC 5/4/2017 Village Dermatology & Cosmetic Surgery LLC 3/8/2017 Lower Manhattan Medical Associates PC 3/14/2017 CI Capital Partners 2/12/2018 Dermatology Associates, Inc. 11/13/2017 R. Todd Plott, M.D., P.A. 6/20/2017 Dermatology Associates of Oklahoma LLC 3/22/2017 Procare Physical Therapy, Inc.

6 20% 15% 10% 5% 0% -5% -10% -15% -20% -25% -30% Dental Products & Providers Medical Devices & Products Medical Product Distribution Specialty Providers Pharma Services Practice Management Provider Services Long Term & Behavioral Care General Providers S&P 500 EBITDA $ (13.2%) (7.6%) 83.5% 2.6% 34.1% 4.1x 11.5x 13.5x 4.0x 11.5x Zimmer Biomet Holdings, Inc. ZBH $ 22, Align Technology, Inc. ALGN 27, % 54.0% 92.1% 36.5% 25.1% 16.7x NM NM 12.5x NM DENTSPLY SIRONA, Inc. XRAY 9, (32.5%) (33.5%) 63.5% 5.3% 17.4% 2.8x 13.5x NM 2.7x 12.4x Henry Schein, Inc. HSIC 11, (20.6%) 3.9% 78.0% 7.4% 8.1% 1.1x 12.8x 26.8x 1.0x 11.9x Cantel Medical Corp. CMN 4, % (4.4%) 75.1% 13.7% 16.6% 5.0x 27.3x 45.1x 4.4x 21.5x Patterson Cos., Inc. PDCO 2, (51.7%) (37.3%) 47.2% 2.0% 4.4% 0.6x 10.2x 10.5x 0.5x 9.8x BIOLASE, Inc. BIOL (75.1%) (43.2%) 23.0% 6.4% (49.1%) 0.4x NM NM 0.4x NM Pro-Dex, Inc. PDEX % (2.2%) 83.1% 14.8% 14.5% 1.0x 6.4x 14.2x 0.9x 6.4x Milestone Scientific, Inc. MLSS (47.3%) (33.1%) 49.4% 32.9% (96.2%) 2.6x NM NM 2.0x NM Birner Dental Management Services, Inc. BDMS (56.2%) (18.5%) 40.7% NM 2.1% 0.3x NM NM NM NM Segment Average (13.4%) (12.2%) 63.6% 13.5% (2.3%) 3.5x 13.6x 22.0x 3.2x 12.3x Segment Median (26.6%) (13.1%) 69.3% 7.4% 11.3% 1.8x 12.1x 14.2x 2.0x 11.7x

7 EBITDA $ (8.3%) (13.2%) 81.8% 5.3% 38.5% 4.5x 13.6x NM 4.2x 11.5x Johnson & Johnson JNJ $ 325, Medtronic Plc MDT 115, (3.5%) 6.0% 96.0% 3.0% 35.2% 4.4x 13.6x 37.7x 4.3x 13.4x Abbott Laboratories ABT 106, % 6.9% 94.4% 12.3% 20.6% 4.6x 24.3x NM 3.9x 15.6x Stryker Corp. SYK 63, % 9.1% 93.9% 10.2% 26.9% 5.4x 19.6x NM 5.0x 17.7x Becton, Dickinson & Co. BDX 64, % 11.9% 96.4% 28.1% 19.9% 6.3x 24.8x NM 4.9x 14.6x Intuitive Surgical, Inc. ISRG 54, % 31.1% 96.3% 16.0% 36.9% 15.7x NM NM 14.1x NM Boston Scientific Corp. BSX 45, % 31.9% 87.7% 9.6% 28.0% 5.4x 19.7x NM 5.0x 17.0x Baxter International, Inc. BAX 39, % 14.2% 97.6% 8.0% 22.9% 3.7x 17.6x 49.1x 3.5x 14.5x Edwards Lifesciences Corp. EW 30, % 29.2% 93.8% 17.0% 31.7% 8.8x 28.7x NM 7.6x 23.2x Zimmer Biomet Holdings, Inc. ZBH 22, (13.2%) (7.6%) 83.5% 2.6% 34.1% 4.1x 11.5x 13.5x 4.0x 11.5x ABIOMED, Inc. ABMD 18, % 118.3% 90.7% 38.2% 29.0% 30.1x NM NM 22.4x NM Integra LifeSciences Holdings Corp. IART 5, % 34.6% 95.4% 18.8% 23.4% 5.7x 24.8x NM 4.4x 18.4x Wright Medical Group NV WMGI 2, (5.6%) 16.9% 86.9% 11.1% 10.5% 4.6x 41.7x NM 4.1x 27.6x EBITDA $ 16.9% 6.3% 94.1% 8.6% 22.7% 4.2x 17.2x 27.3x 3.9x 16.1x Danaher Corp. DHR $ 68, Stryker Corp. SYK 63, % 9.1% 93.9% 10.2% 26.9% 5.4x 19.6x NM 5.0x 17.7x McKesson Corp. MCK 26, (18.9%) (14.5%) 74.6% 4.5% 2.0% 0.2x 8.4x NM 0.2x 7.7x Cardinal Health, Inc. CAH 15, (37.3%) (20.3%) 61.9% 4.4% 2.7% 0.2x 6.8x 9.1x 0.2x 7.4x AmerisourceBergen Corp. ABC 18, (9.8%) (7.1%) 80.2% 10.9% 1.6% 0.1x 9.1x 22.1x 0.1x 8.8x Henry Schein, Inc. HSIC 11, (20.6%) 3.9% 78.0% 7.4% 8.1% 1.1x 12.8x 26.8x 1.0x 11.9x Patterson Cos., Inc. PDCO 2, (51.7%) (37.3%) 47.2% 2.0% 4.4% 0.6x 10.2x 10.5x 0.5x 9.8x Owens & Minor, Inc. OMI 1, (48.1%) (11.5%) 51.4% 8.5% 2.5% 0.2x 7.9x 16.4x 0.2x 6.1x Aceto Corp. ACET (78.3%) (67.6%) 19.6% (6.9%) 1.5% 0.5x 7.0x NM 0.5x 14.7x EBITDA $ 4.2% (4.2%) 86.9% 7.6% 16.4% 1.9x 12.7x 21.0x 1.9x 10.1x Fresenius Medical Care AG & Co. KGaA FMS $ 31, DaVita, Inc. DVA 12, % (3.9%) 86.0% 7.0% 19.4% 1.7x 10.4x 32.1x 1.9x 10.4x Encompass Health Corp. HLS 6, % 37.1% 97.3% 7.6% 20.6% 2.4x 11.4x 23.9x 2.2x 10.9x MEDNAX, Inc. MD 4, (28.3%) (19.0%) 68.7% 8.6% 14.5% 1.7x 10.3x 12.2x 1.6x 9.4x Envision Healthcare Corp. AMSG 5, (29.8%) 27.3% 69.5% 9.0% 11.8% 1.2x 9.4x NM 1.1x 9.7x LHC Group, Inc. LHCG 2, % 39.7% 97.9% 79.6% 7.4% 2.7x NM 33.8x 0.9x 9.1x American Renal Associates Holdings, Inc. ARA (15.0%) (9.4%) 65.5% 11.9% 18.5% 1.7x 7.7x NM 1.5x 10.9x AAC Holdings, Inc. AAC % 4.1% 71.8% 12.9% 14.9% 1.6x 12.0x NM 1.4x 6.8x

8 EBITDA $ 17.7% 16.8% 94.3% 5.3% 18.5% 1.6x 8.4x 13.9x 1.5x 8.1x HCA Healthcare, Inc. HCA $ 35, Universal Health Services, Inc. UHS 9, (8.7%) (1.7%) 87.0% 6.4% 16.6% 1.4x 8.5x 13.8x 1.3x 7.9x Tenet Healthcare Corp. THC 3, % 121.4% 86.5% (5.0%) 13.6% 1.0x 8.3x NM 1.1x 7.6x LifePoint Health, Inc. LPNT 1, (27.3%) (2.0%) 71.8% 2.5% 11.8% 0.8x 7.4x NM 0.8x 6.5x Community Health Systems, Inc. CYH (66.7%) (22.1%) 32.7% (7.2%) 11.5% 1.0x 15.0x NM 1.1x 9.3x EBITDA $ (20.0%) (11.2%) 76.6% 3.9% 6.0% 0.5x 7.0x 9.9x 0.5x 6.9x CVS Health Corp. CVS $ 65, Express Scripts Holding Co. ESRX 43, % 3.4% 90.8% 1.6% 6.0% 0.6x 7.7x 9.7x 0.6x 7.3x Perrigo Co. Plc PRGO 10, (3.5%) (16.3%) 76.0% 2.7% 22.0% 2.6x 11.3x NM 2.5x 10.9x Magellan Health, Inc. MGLN 2, % (0.6%) 85.5% 20.8% 2.6% 0.4x 9.2x 22.7x 0.3x 6.4x Allscripts Healthcare Solutions, Inc. MDRX 2, (6.0%) (17.5%) 74.4% 17.2% 12.0% 2.2x 16.2x NM 1.9x 9.4x EBITDA $ 37.1% 22.4% 99.3% 9.7% NM 0.4x NM 27.2x 0.4x 8.4x WellCare Health Plans, Inc. WCG $ 11, HealthEquity, Inc. HQY 4, % 61.0% 91.5% 26.5% 35.8% 18.0x NM NM 14.4x 36.4x EBITDA $ (10.0%) (11.3%) 81.0% 8.1% 26.9% 3.7x 12.8x 23.6x 3.5x 11.4x Cerner Corp. CERN $ 19, Healthcare Services Group, Inc. HCSG 3, (7.8%) (18.1%) 76.9% 9.0% 0.1% 1.6x 30.0x 48.5x 1.5x 19.1x Omnicell, Inc. OMCL 2, % 8.1% 94.7% 10.7% 7.1% 2.9x 29.2x NM 2.7x 16.4x HMS Holdings Corp. HMSY 1, % 27.6% 91.5% 7.9% 19.4% 3.6x 15.8x 41.6x 3.4x 14.3x Evolent Health, Inc. EVH 1, (17.0%) 71.1% 77.5% 33.6% 10.6% 3.2x NM NM 2.4x NM Providence Service Corp. PRSC 1, % 32.4% 98.7% 2.8% 4.4% 0.6x 14.4x 20.9x 0.6x 12.0x

9 EBITDA $ (17.2%) 25.4% 75.3% 8.9% 18.7% 2.4x 11.5x NM 2.1x 10.2x Acadia Healthcare Co., Inc. ACHC $ 3, The Ensign Group, Inc. ENSG 1, % 61.4% 89.3% 9.3% 8.8% 1.1x 14.1x 31.1x 1.0x 10.7x National HealthCare Corp. NHC 1, % 15.5% 96.1% NM 11.3% 1.0x 9.7x 26.4x NM NM Civitas Solutions, Inc. CIVI (6.3%) (4.1%) 82.4% 7.1% 8.3% 0.9x 9.0x NM 0.8x 7.7x AAC Holdings, Inc. AAC % 4.1% 71.8% 12.9% 14.9% 1.6x 12.0x NM 1.4x 6.8x SunLink Health Systems, Inc. SSY (22.3%) (18.9%) 62.0% NM (2.0%) 0.2x NM NM NM NM

10

11

Date Target Buyer(s) Segment ($ in Mil) Rev EBITDA 3/28/2018 Albert Einstein Healthcare Network Jefferson Health System, Inc. General Providers - - -

Date Target Buyer(s) Segment ($ in Mil) Rev EBITDA 3/28/2018 Albert Einstein Healthcare Network Jefferson Health System, Inc. General Providers - - - 50 40 30 20 10-5 18 2 45 16 5 7 12 19 Financial 10% Strategic 90% Amount Date Target Buyer(s) Segment Rev EBITDA 3/28/2018 Albert Einstein Healthcare Network Jefferson Health System, Inc. General Providers

More information

9/22/2017 Argon Medical Devices, Inc. WW Medical & Healthcare Co. Ltd. Medical Devices & Products x -

9/22/2017 Argon Medical Devices, Inc. WW Medical & Healthcare Co. Ltd. Medical Devices & Products x - 50 40 30 20 10-2 9 39 4 32 19 6 10 13 34 Financial 17% Strategic 83% Date Target Buyer(s) Segment Amount Rev EBITDA 9/28/2017 Jefferson Radiology PC / Jefferson Imaging MEDNAX, Inc. Specialty Providers

More information

Healthcare M&A Report Q4 2017

Healthcare M&A Report Q4 2017 John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383-0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383-0206 Keith Hodgdon Managing Director hodgdon@hydeparkcapital.com

More information

Healthcare Products & Services Industry Update Q2 2017

Healthcare Products & Services Industry Update Q2 2017 Healthcare Products & Services Industry Update Q2 2017 Q2 M&A TRANSACTION SUMMARY Q2 Deal Volume (1) Healthcare Products & Services M&A decreased slightly following increased transaction activity in Q1

More information

Healthcare M&A Report Q2 2018

Healthcare M&A Report Q2 2018 Integrity Expertise Results John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383-0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383-0206 Healthcare M&A

More information

HEALTHCARE REPORT Q Explore M&A Activity, Capital Market Conditions and Current Trends for the Healthcare Industry SDRVENTURES.

HEALTHCARE REPORT Q Explore M&A Activity, Capital Market Conditions and Current Trends for the Healthcare Industry SDRVENTURES. HEALTHCARE REPORT Q2 2016 Explore M&A Activity, ital Conditions and Current Trends for the Healthcare Industry Investment Banking & Securities Offered Through SDR ital s, Inc., Member FINRA & SIPC. Q2

More information

Coker Capital s Healthcare Services Newsletter Update on the Radiology Sector

Coker Capital s Healthcare Services Newsletter Update on the Radiology Sector Healthcare M&A Advisory October 2018 Coker Capital s Healthcare Services Newsletter Update on the Radiology Sector In this issue of the Coker Capital Healthcare Services Newsletter, we provide an overview

More information

HEALTHCARE SERVICES MARKET UPDATE SPRING 2018

HEALTHCARE SERVICES MARKET UPDATE SPRING 2018 MERGERS & ACQUISITIONS CAPITAL RAISES FINANCIAL & STRATEGIC ADVISORY HEALTHCARE SERVICES MARKET UPDATE SPRING 2018 TRENDS & COMMENTARY The Song Remains the Same The number of healthcare services M&A transactions

More information

Deals and Dealmakers. The Health Care M&A Review Fourth Quarter 2017

Deals and Dealmakers. The Health Care M&A Review Fourth Quarter 2017 Deals and Dealmakers The Health Care M&A Review Fourth Quarter 217 Irving Levin Associates Publications and Services Subscriptions & Memberships The SeniorCare Investor www.healthcaremanda.com Dealmakers

More information

Healthcare Services Industry Update July 2013

Healthcare Services Industry Update July 2013 Healthcare Services Industry Update July 2013 Mergers & Acquisitions Business Valuation Strategic Consulting Corporate Finance Industry Snapshot: Healthcare Notable M&A Activity Capital Markets 7/15/13.

More information

Healthcare. In This Issue: Industry Report. Medical Device Q4, 2017

Healthcare. In This Issue: Industry Report. Medical Device Q4, 2017 Industry Report Medical Device Q4, 217 Healthcare In This Issue: Industry News Transactions State of the Industry About Mirus Mirus Healthcare Spotlight 2 Summit Drive, 4th Floor (South) Burlington, MA

More information

Healthcare Services Industry Update June 2013

Healthcare Services Industry Update June 2013 Healthcare Services Industry Update June 2013 Mergers & Acquisitions Business Valuation Strategic Consulting Corporate Finance Industry Snapshot: Healthcare Notable M&A Activity 6/5/13. Bayer HealthCare,

More information

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease

More information

Healthcare Transaction Volume Remains High, But Have M&A Valuation Multiples Peaked? ,578 3,006

Healthcare Transaction Volume Remains High, But Have M&A Valuation Multiples Peaked? ,578 3,006 # of Transactions HEALTHCARE The change in control of the U.S. House of Representatives from Republican to Democrat, coupled with a slightly stronger Republican hold on the Senate, makes it unlikely any

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary

More information

HEALTHCARE SERVICES MARKET UPDATE FALL 2017

HEALTHCARE SERVICES MARKET UPDATE FALL 2017 MERGERS & ACQUISITIONS CAPITAL RAISES FINANCIAL & STRATEGIC ADVISORY HEALTHCARE SERVICES MARKET UPDATE FALL 2017 TRENDS & COMMENTARY 60% of the Time, It Works Every Time The Affordable Care Act has occupied

More information

Healthcare Focus. Trends in Capital Flows into Healthcare

Healthcare Focus. Trends in Capital Flows into Healthcare Healthcare Focus ISSUE 9 VOLUME 1 Fall 2 DRESNER PARTNERS INVESTMENT BANKING Pharmaceuticals Trends in Capital Flows into Healthcare Since the start of the recession (in December 27, according to the National

More information

Healthcare Deals for June 2018

Healthcare Deals for June 2018 Analogic Developer of leading-edge healthcare and security technology designed for clinical testing. The company offers advanced imaging and real-time guidance technology used in computed tomography (CT),

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

Healthcare & Life Sciences Industry Update 2018 Year-End Review

Healthcare & Life Sciences Industry Update 2018 Year-End Review Healthcare & Life Sciences Industry Update Year-End Review As of 12/31/ Mergers & Acquisitions Support Business Valuation Corporate Finance The McLean Group 7918 Jones Branch Drive, Suite 750 McLean, VA

More information

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable

More information

Healthcare Services Industry Update. Mergers & Acquisitions Business Valuation Strategic Consulting Corporate Finance

Healthcare Services Industry Update. Mergers & Acquisitions Business Valuation Strategic Consulting Corporate Finance Healthcare Services Industry Update Mergers & Acquisitions Business Valuation Strategic Consulting Corporate Finance Industry Snapshot: Healthcare Notable M&A Activity Capital Markets 3/12/13. Athenahealth,

More information

Previous Attendees List:

Previous Attendees List: Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare

More information

VentureSource Europe -- 3Q 2014

VentureSource Europe -- 3Q 2014 Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a

More information

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the

More information

MEDICAL DEVICE OUTSOURCING Q BOSTON CHICAGO LONDON LOS ANGELES NEW YORK ORANGE COUNTY PHILADELPHIA SAN DIEGO SILICON VALLEY TAMPA CONTACTS

MEDICAL DEVICE OUTSOURCING Q BOSTON CHICAGO LONDON LOS ANGELES NEW YORK ORANGE COUNTY PHILADELPHIA SAN DIEGO SILICON VALLEY TAMPA CONTACTS MEDICAL DEVICE OUTSOURCING CONTACTS Eric Williams Managing Director (215) 854-4065 ewilliams@capstonellc.com Mark Surowiak Director (215) 854-4063 msurowiak@capstonellc.com Matthew Szymanski Associate

More information

CeQur establishes Wales subsidiary

CeQur establishes Wales subsidiary FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,

More information

Monetizing Early-Stage R&D Assets. March 18, 2015

Monetizing Early-Stage R&D Assets. March 18, 2015 Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst

More information

M&A Review. North America. April 2017

M&A Review. North America. April 2017 M&A Review North America April 2017 The following report details mergers and acquisitions activity in North America in April 2017 using data from the Zephyr database. It focuses on deal activity by target

More information

Paragon Ventures. Healthcare Mergers and Strategic Acquisitions

Paragon Ventures. Healthcare Mergers and Strategic Acquisitions Paragon Ventures Healthcare Mergers and Strategic Acquisitions Are you plugged in to your STRATEGIC OPTIONS? Buy A Business Sell A Business Valuations Strategic Plans Exit Strategies Recapitalization Paragon

More information

Over the past seven years, there has been an

Over the past seven years, there has been an The Dermatology Market: A Tidal Wave of Private Equity Investment A beginner s guide to the complex world of mergers and acquisitions. BY CLINT BUNDY Over the past seven years, there has been an explosion

More information

HEALTHCARE & LIFE SCIENCES

HEALTHCARE & LIFE SCIENCES www.harriswilliams.com Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is private limited

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar

More information

Hitting an Inflection; Reiterate OW

Hitting an Inflection; Reiterate OW March 1, 2016 Nevro Corp Hitting an Inflection; Reiterate OW MORGAN STANLEY & CO. LLC David R. Lewis David.R.Lewis@morganstanley.com Jonathan L Demchick Jonathan.Demchick@morganstanley.com +1 415 576-2324

More information

Florida M&A Report 2013

Florida M&A Report 2013 John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383 0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383 0206 Keith Hodgdon Senior Vice President hodgdon@hydeparkcapital.com

More information

KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017

KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017 KKR & Co. L.P. Goldman Sachs U.S. Financial Services Conference: December 6, 2017 KKR Growth in Alternative Asset Market Share KKR AUM +20% CAGR Alternative AUM +12% CAGR ($ in trillions) ($ in billions)

More information

1 st Quarter Earnings Conference Call

1 st Quarter Earnings Conference Call 1 st Quarter Earnings Conference Call KKR & Co. L.P. Investor Update April 27, 2017 1Q17 Reflections Key Business Themes Performance this quarter was strong as our model enabled us to capture more of everything

More information

IMAPjune Medical Devices. IMAP M&A sector report

IMAPjune Medical Devices. IMAP M&A sector report IMAPjune 2017 Medical Devices IMAP M&A sector report Medtech opportunities in numbers there are strong underlying fundamentals and high valuations making this segment attractive 150% PROJECTED INCREASE

More information

Chairman Estrada asked the Secretary to call upon the registered public speakers. The Secretary called upon the following registered speaker:

Chairman Estrada asked the Secretary to call upon the registered public speakers. The Secretary called upon the following registered speaker: Minutes of the meeting of the Finance Committee of the Board of Directors of the Cook County Health and Hospitals System held Thursday, February 15, 2018 at the hour of 8:30 A.M., at 1900 W. Polk Street,

More information

Ronald Lee Davidson SW 40th Moore, Oklahoma Phone: (405) Fax: (405)

Ronald Lee Davidson SW 40th Moore, Oklahoma Phone: (405) Fax: (405) Ronald Lee Davidson 1504 SW 40th Moore, Oklahoma 73160 Phone: (405) 250-2030 Fax: (405) 759-2275 Email: Ron@Mintiva.com PERSONAL INFORMATION - PLACE OF BIRTH USA GENDER Male MARITAL STATUS Married EDUCATION

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Aqua Pharmaceuticals, LLC

Aqua Pharmaceuticals, LLC Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing

More information

HEALTHCARE & LIFE SCIENCES

HEALTHCARE & LIFE SCIENCES www.harriswilliams.com Investment banking services are provided by Harris Williams LLC, a registered broker-dealer and member of FINRA and SIPC, and Harris Williams & Co. Ltd, which is a private limited

More information

Method of Declaration. Hospitality/Interest/Sponsorship

Method of Declaration. Hospitality/Interest/Sponsorship Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12

More information

Gabelli & Company, Inc.

Gabelli & Company, Inc. One Corporate Center Rye, NY 10580-1422 Tel. (914) 921-8436 Fax (914) 921-5098 www.gabelli.com Gabelli & Company, Inc. Investment Summary Kensey Nash Corp. (KNSY), headquartered in Exton, PA, is a developer

More information

Device M&A Rebound Continues: With Ardian, Sadra Deals Show Appetite For Big, Early-Stage Acquisitions

Device M&A Rebound Continues: With Ardian, Sadra Deals Show Appetite For Big, Early-Stage Acquisitions Page 1 of 6 RELATED ARTICLES FDC-Windhover Device M&A Rebound Continues: With Ardian, Sadra Deals Show Appetite For Big, Early-Stage Acquisitions By David Cassak, Tom Salemi, In Vivo 12/01/2010 Around

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 4Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Baxter 2007 Investor Conference March 14, 2007

Baxter 2007 Investor Conference March 14, 2007 Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide

More information

Management to Host Conference Call at 8:30 a.m. ET today

Management to Host Conference Call at 8:30 a.m. ET today Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),

More information

HEALTHCARE ADVISORY SERVICES

HEALTHCARE ADVISORY SERVICES HEALTHCARE ADVISORY SERVICES Building Value In Healthcare Real Estate HEALTHCARE ADVISORY SERVICES TRANSWESTERN REAL ESTATE SERVICES DEDICATED TO HEALTHCARE Transwestern s Healthcare Advisory Services

More information

4 th Quarter Earnings Conference Call

4 th Quarter Earnings Conference Call 4 th Quarter Earnings Conference Call KKR & Co. L.P. Investor Update February 11, 2016 Gross Returns $1B+ Carry Paying Funds Q4 and 2015 Performance Market Indices Private Equity Real Assets Alternative

More information

Omeros Raises More Than $63 Million in Financing

Omeros Raises More Than $63 Million in Financing Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,

More information

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

Q2-Q Deal Values Remain High Led by Active Strategic Buyers and Private Equity Groups 1,905 1,881

Q2-Q Deal Values Remain High Led by Active Strategic Buyers and Private Equity Groups 1,905 1,881 HEALTHCARE Q2-Q3 2017 Deal Values Remain High Led by Active Strategic Buyers and Private Equity Groups M&A transaction values have continued to increase across all subsectors of the healthcare industry

More information

Digitalization and TITLE OF. Devices May 2018 PRESENTATION

Digitalization and TITLE OF. Devices May 2018 PRESENTATION Digitalization and Globalization TITLE OF of Medical Devices May 2018 PRESENTATION R&D Spend (in Bn) Consolidated ER&D Spending : E-R&D spend is highly consolidated among top 5 OEMs; Imaging and Non-imaging

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis. DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.

More information

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018

KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018 KKR & Co. L.P. Morgan Stanley Financials Conference: June 13, 2018 ($ in trillions) KKR Growth in Alternative Asset Market Share KKR AUM +20% CAGR +21% CAGR Alternative AUM +12% CAGR $190 (1) ($ in billions)

More information

Venture Capital Report

Venture Capital Report Venture Capital Report U.S. 4Q 2017 The following report presents Dow Jones VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts

More information

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context

More information

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated

More information

Heart Valve Summit: Medical, Surgical and Interventional Decision Making

Heart Valve Summit: Medical, Surgical and Interventional Decision Making Disclosure/Conflict of Interest Statement As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American

More information

Life Sciences Tools, Diagnostics, & Services Q Industry Overview

Life Sciences Tools, Diagnostics, & Services Q Industry Overview Life Sciences Tools, Diagnostics, & Services Q4 2017 Industry Overview Life Sciences Tools, Diagnostics, & Services: Industry Overview Key Takeaways M&A activity has remained steady at high volumes of

More information

Global Robotic Surgery Market: Industry Analysis & Outlook ( )

Global Robotic Surgery Market: Industry Analysis & Outlook ( ) Industry Research by Koncept Analytics Global Robotic Surgery Market: Industry Analysis & Outlook ----------------------------------------- (2017-2021) June 2017 1 Executive Summary Medical robotics is

More information

Quarterly M&A Report Q3 2018

Quarterly M&A Report Q3 2018 John Hill hill@hydeparkcapital.com (813) 383-0205 John McDonald mcdonald@hydeparkcapital.com (813) 383-0206 Jeff Hendricks Vice President jhendricks@hydeparkcapital.com (678) 523 3073 Quarterly M&A Report

More information

The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors

The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors Conference Program Tuesday October 17, 2017 Hilton Boston Dedham TABLE OF CONTENTS SECTION PAGE OUR PARTNERS Thank

More information

Office of Inspector General Update

Office of Inspector General Update Office of Inspector General Update 15th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum November 3, 2014 Mary E. Riordan, Senior Counsel Office of Counsel to the Inspector

More information

Venture Capital Report

Venture Capital Report Europe 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs

More information

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,

More information

direct Assistant: Jeanne Tomazin

direct Assistant: Jeanne Tomazin BRIAN R. BROWDER Partner, Immediate Past Chair, Healthcare Department 615.850.8636 direct brian.browder@wallerlaw.com Assistant: Jeanne Tomazin 615.850.8557 jeanne.tomazin@wallerlaw.com Nashville City

More information

Invoices Distributed Over 25k in Value for Period: June 2018

Invoices Distributed Over 25k in Value for Period: June 2018 Invoices Distributed Over 25k in Value for Period: June 2018 Distribution Period Supplier Name AP Invoice Number AP Invoice Date Jun-18 HSL (FM) LLP IN000585 01/06/2018 Jun-18 NHS SUPPLY CHAIN - MAINTENANCE

More information

Final Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV

Final Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV Final Pitch Competition PROGRAM GUIDE Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV #HITVenture #HIMSS16 1 Presented by: WEDNESDAY, MARCH

More information

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number

More information

Capstone Partners. Medical Device Outsourcing. Market Intelligence for Business Owners Q Coverage Report. Investment Banking Advisors

Capstone Partners. Medical Device Outsourcing. Market Intelligence for Business Owners Q Coverage Report. Investment Banking Advisors Coverage Report Market Intelligence for Business Owners Q1 2013 Capstone Partners Investment Banking Advisors BOSTON CHICAGO LOS ANGELES PHILADELPHIA SAN DIEGO SILICON VALLEY Coverage Report MARKET FACTORS

More information

2 nd Quarter Earnings Conference Call

2 nd Quarter Earnings Conference Call 2 nd Quarter Earnings Conference Call KKR & Co. Inc. Investor Update July 26, 2018 Recent Milestones K-1 $ Converted to a Corporation on July 1, 2018 Investor Day held on July 9, 2018 2 Key Metrics Assets

More information

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers

More information

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,

More information

REGISTER OF THE INTERESTS OF MEMBERS OF THE TRUST BOARD

REGISTER OF THE INTERESTS OF MEMBERS OF THE TRUST BOARD REGISTER OF THE INTERESTS OF MEMBERS OF THE TRUST BOARD Board Member and Dominic Dodd, Chair 8/4/16 Non-executive s ships ship Director of UCLPartners 1 Member of I s Chairs Advisory Group. Unpaid. to

More information

REGENTS MEDICAL AT LA JOLLA FOR LEASE 4150 REGENTS PARK ROW 4130 LA JOLLA VILLAGE DR. LA JOLLA, CA 92037

REGENTS MEDICAL AT LA JOLLA FOR LEASE 4150 REGENTS PARK ROW 4130 LA JOLLA VILLAGE DR. LA JOLLA, CA 92037 FOR LEASE REGENTS MEDICAL AT LA JOLLA TRAVIS IVES Senior Director 858 334 4041 travis.ives@cushwake.com CA License #01889097 JOE ZUREK Associate 858 558 5612 joe.zurek@cushwake.com CA License #01967813

More information

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp 2012 Trends in Terms of U.S. Life Science Venture Financings Full Year 2012 Fenwick fenwick & west llp 2012 Trends in Terms of U.S. Life Science Venture Financings Full Year 2012 Survey Intro and Background

More information

Born Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.

Born Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Board of Directors Håkan Björklund Chairman Born 1956. Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Other appointments: Currently serves as Industry Executive at Avista Capital

More information

Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting

Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting Tokyo, Japan March 16, 2010 Astellas Pharma Inc. (TSE: 4503) today notified

More information

Mid-Market Investment Banking

Mid-Market Investment Banking Selected Divestiture Transactions Sale to Knowledge First Financial Sale to Total Power Sale to TorQuest Partners Sale to SK Capital Sale of its its Ontario Standard Precast Concrete Division to Ironbridge

More information

4 th Quarter Earnings Conference Call

4 th Quarter Earnings Conference Call 4 th Quarter Earnings Conference Call KKR & Co. L.P. Investor Update February 9, 2017 Healthy Level of New Capital Raised Year-Over-Year Capital Inflows Driving Asset Growth ($ in billions) $92 +11% $101

More information

Capstone Headwaters MEDICAL DEVICE OUTSOURCING Q TABLE OF CONTENTS MERGER & ACQUISTION OVERVIEW CONTRIBUTORS

Capstone Headwaters MEDICAL DEVICE OUTSOURCING Q TABLE OF CONTENTS MERGER & ACQUISTION OVERVIEW CONTRIBUTORS Capstone Headwaters MEDICAL DEVICE OUTSOURCING Q1 2019 TABLE OF CONTENTS M&A Overview Key Trends & Drivers CSHW Deal Highlight Notable Transactions Case Study Select Transactions Firm Track Record CONTRIBUTORS

More information

4 th Quarter Earnings Conference Call

4 th Quarter Earnings Conference Call 4 th Quarter Earnings Conference Call KKR & Co. Inc. Investor Update February 1, 2019 Key Metrics Assets Under Management Management Fees ($ in billions) ($ in millions) $195 $1,069 $168 $905 $100 $107

More information

Using Academic Licensing Agreements to Promote Global Social Responsibility

Using Academic Licensing Agreements to Promote Global Social Responsibility Using Academic Licensing Agreements to Promote Global Social Responsibility Equitable Licensing of Medical Research Results Charité - Universitätsmedizin Berlin April 26, 2009 Dr. Ashley J. Stevens Executive

More information

Digital Medical Device Innovation: A Prescription for Business and IT Success

Digital Medical Device Innovation: A Prescription for Business and IT Success 10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing

More information

VentureSource U.S. -- 4Q 2013

VentureSource U.S. -- 4Q 2013 U.S. -- 4Q 2013 The following report presents DJX VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive

More information

Chaired by: Keith Gregg, MBA, CLP, Chairman, JRG VENTURES and Entrepreneur-in- Residence for Health Technology, NASHVILLE ENTREPRENEUR CENTER

Chaired by: Keith Gregg, MBA, CLP, Chairman, JRG VENTURES and Entrepreneur-in- Residence for Health Technology, NASHVILLE ENTREPRENEUR CENTER Wednesday, September 19, Forum: Technology and New Healthcare Business Models With the Supreme Court decision, healthcare systems must look into blossoming technology innovations to improve patient care,

More information

Provident Perspectives: Consolidation in Anesthesia

Provident Perspectives: Consolidation in Anesthesia Provident Perspectives: Consolidation in Anesthesia Merger and acquisition activity in the anesthesia healthcare vertical continues to see a large inflow of private equity capital. An everchanging healthcare

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

NORTH AUSTIN II WILKE LANE PFLUGERVILLE, TX 78660

NORTH AUSTIN II WILKE LANE PFLUGERVILLE, TX 78660 NORTH AUSTIN II 19447 WILKE LANE PFLUGERVILLE, TX 78660 Erik Carlson, BRE#1347649 Senior Advisor and Vice President 408.392.8822 erik.carlson@svn.com CalBRE #1347649 Paul Getty, BRE#01705899 President

More information

Life Sciences & Healthcare Venture Summit. Funding Healthcare & IT Media October 27, 2009

Life Sciences & Healthcare Venture Summit. Funding Healthcare & IT Media October 27, 2009 Life Sciences & Healthcare Venture Summit Funding Healthcare & IT Media October 27, 2009 Emilio Ragosa Emilio Ragosa is a partner in Morgan Lewis's Business and Finance Practice. He focuses primarily on

More information

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions

More information

BOARD OF DIRECTORS. PETER WEHRLY Chair

BOARD OF DIRECTORS. PETER WEHRLY Chair BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held

More information

COMPANY JOB TITLE COUNTRY

COMPANY JOB TITLE COUNTRY COMPANY JOB TITLE COUNTRY 4 Tech Cardio Research & Development Ireland 4Tech Cardio Research & Development Ireland 4Tech Cardio Production/Manufacturing Ireland 4Tech Cardio Production/Manufacturing Ireland

More information

Healthcare in China and in US - opportunites

Healthcare in China and in US - opportunites Healthcare in China and in US - opportunites Ming Wang, MD, PhD Founding president, Tennessee Chinese Chamber of Commerce Founder and chairman, Wang Foundation for Sight Restoration International president,

More information